FMI was established as machining company in 1962, with our first production plant located in Bergen op Zoom.Our current group of companies originated after a management buyout in 2001. Since then, we have grown into group of manufacturing companies using the very latest engineering technologies, computer aided manufacturing, additive manufacturing and CNC machining production technologies. Our products and services range from component manufacturing through to the assembly of modules and turn-key integrated systems.
Today, FMI has 9 engineering and manufacturing locations. With our subsidairy 21 Groep, an industrial service provider included, FMI has more than 400 employees. We focus Original Equipment Manufacturers and end-product manufacturers in our main markets: high-technology, industry, food and medical. FMI is privately owned and we have a solid financial base.
Please for more information visit:https://www.fmi-international.com
The Spinal implants and spinal devices market, by technology, includes spinal fusion and fixation, vertebral compression fracture treatment, and motion preservation/non-fusion technologies. On the basis of products, the global spinal implants and spinal devices market is divided into six major segments, namely, thoracic fusion and lumbar fusion devices, cervical fusion devices, spine biologics, vertebral compression fracture treatment devices, motion preservation/non-fusion treatment devices, and spine bone stimulators. Bases on the type of surgery, the global spinal implants and spinal devices market is divided into two segments, namely, open surgery and minimally invasive surgery. The spinal decompression devices market, by type of procedure, covers discectomy, laminotomy/laminectomy, foraminotomy/foraminectomy, facetectomy, and corpectomy procedures.
The Spinal market is expected to reach USD 15.73 Billion by 2020, growing at a CAGR of 5.6% from 2015 to 2020. As of 2015, North America is estimated to hold the largest share of the global spinal implants and spinal devices market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 8.2% from 2015 to 2020. A number of factors, including rising healthcare expenditure in developing nations owing to growing income levels, increasing government funding, presence of a large patient population, rising obesity cases, and growing awareness on the newly developed spine treatment techniques and devices are propelling the growth of the spinal implants and spinal devices market in the Asia-Pacific region. However, challenges associated with this market, such as scarcity of expertise and trained healthcare workers and lack of adequate patient awareness restricts the market growth in this region. Source: marketsandmarkets.com